Cleveland Clinic Researchers Validate... - Fight Prostate Ca...

Fight Prostate Cancer

3,036 members1,517 posts

Cleveland Clinic Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer - Feb 13, 2020

cujoe profile image
4 Replies

New gene variant identified for advance PCa. From the Cleveland Clinic Press Release:

"This study – the first clinical trial validation of the relationship between HSD3B1 status and clinical outcomes – suggests that genetic testing for HSD3B1(1245C) may help physicians identify patients most likely to benefit from additional and more aggressive treatment . . .

Taken together, these findings suggest that the presence or absence of this genetic variant can be used to help identify men with low-volume metastatic prostate cancer most at risk for quick progression to treatment resistance and earlier death – a discovery with significant implications for clinical care and genetic counseling."

Full Press Release is here:

newsroom.clevelandclinic.or...

And the abstract and full article in JAMA Oncology is available here:

jamanetwork.com/journals/ja...

And a VERY informative 11+ minute JAMA Oncology interview with study author Nima Sharifi, M.D is here:

edhub.ama-assn.org/jn-learn...

Good Stuff (It's coming) - Be Well - K9 terror

Written by
cujoe profile image
cujoe
To view profiles and participate in discussions please or .
Read more about...
4 Replies
NPfisherman profile image
NPfisherman

Thanks for posting K9 Amigo,

The Science continues to develop as they look at genetic variability and survivability and approaches to treatment. It is why I believe we will hit chronic disease status within a few years and the 5 year survival rate will change dramatically...Another genetic variant to be aware of at the start of treatment...

Be well...

Fish

marnieg46 profile image
marnieg46

The podcast was great cujoe. Thank you. Easy to understand and informative. This article from UroToday taken from ASCO 2019 touches on some of the information gleaned from the trials.

urotoday.com/conference-hig...

cujoe profile image
cujoe in reply tomarnieg46

Thanks, Marnie. UroToday piece is a good review of the CC research. I now see that the JAMAnetwork link puts the full report behind a paywall. Insert this doi (doi:10.1001/jamaoncol.2019.6496) into this SciHub link to get a PDF download of the full report.

sci-hub.se/

BTW, SciHub works for access to nearly all research reports.

Open access to Information provides the fuel for Knowledge. Be Well - K9

marnieg46 profile image
marnieg46 in reply tocujoe

Thanks K9 I'll check it out. UBW2.

Not what you're looking for?

You may also like...

The Role of HSD3B1 in Prostate Cancer Progression and Treatment

I don't think I was tested against this gene, so I think it could be important for me as well. A...
Maxone73 profile image

Nitric Oxide -- slows prostate cancer progression and PSA doubling time.

Note the articles title and published date on NIH.gov: "Current...
George71 profile image

Glowing dye helps surgeons eradicate prostate cancer

"A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in...
Justfor_ profile image

Apalutamide as first-line treatment, real-world data

Because sometimes it's nice to know the actual outcomes in day to day clinical practice. A...
Maxone73 profile image

Welcoming New Era of Expanded Use of Radiotherapies

Duplicating this for my friends at FPC. This is the short take from Practice Update this morning....
MateoBeach profile image